Free Trial

Beauty Health (SKIN) Stock Price, News & Analysis

$1.79
-0.03 (-1.65%)
(As of 07/26/2024 ET)
Today's Range
$1.71
$1.83
50-Day Range
$1.76
$2.65
52-Week Range
$1.35
$8.68
Volume
1.85 million shs
Average Volume
1.21 million shs
Market Capitalization
$221.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.86

Beauty Health MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.92 Rating Score
Upside/​Downside
227.2% Upside
$5.86 Price Target
Short Interest
Healthy
11.70% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.11mentions of Beauty Health in the last 14 days
Based on 22 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.07) to $0.03 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.57 out of 5 stars

Medical Sector

507th out of 936 stocks

Surgical & Medical Instruments Industry

67th out of 101 stocks

SKIN stock logo

About Beauty Health Stock (NASDAQ:SKIN)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN Stock Price History

SKIN Stock News Headlines

Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Beauty edit: From lip care to skin perfection
See More Headlines
Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
7/27/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SKIN
Fax
N/A
Employees
1,030
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.86
High Stock Price Target
$23.00
Low Stock Price Target
$1.50
Potential Upside/Downside
+227.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
12 Analysts

Profitability

Net Income
$-100,120,000.00
Pretax Margin
-20.17%

Debt

Sales & Book Value

Annual Sales
$398 million
Book Value
$0.48 per share

Miscellaneous

Free Float
72,943,000
Market Cap
$221.30 million
Optionable
Optionable
Beta
0.96
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Marla Malcolm Beck (Age 54)
    President, CEO & Director
    Comp: $1.66M
  • Mr. Michael P. Monahan (Age 52)
    Chief Financial Officer
    Comp: $311.32k
  • Mr. Daniel Copell Watson (Age 61)
    Chief Revenue Officer
    Comp: $545.55k
  • Mr. Bradley Hauser (Age 47)
    Advisor
    Comp: $608.8k
  • Ms. Sheri Lewis (Age 58)
    Chief Supply Chain & Operations Officer
  • Mr. Paul Bokota
    VP & General Counsel
  • Ms. Celeste Ortiz
    Chief Human Resources Officer
  • Mr. Mingo Ku
    President of APAC
  • Mr. Jon Arnold
    President of EMEA

SKIN Stock Analysis - Frequently Asked Questions

How have SKIN shares performed this year?

Beauty Health's stock was trading at $3.11 at the beginning of the year. Since then, SKIN stock has decreased by 42.4% and is now trading at $1.79.
View the best growth stocks for 2024 here
.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) released its quarterly earnings data on Thursday, May, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. Beauty Health's quarterly revenue was down 5.7% compared to the same quarter last year.

Who are Beauty Health's major shareholders?

Top institutional investors of Beauty Health include Bank of New York Mellon Corp (0.28%) and 180 Wealth Advisors LLC (0.08%). Insiders that own company stock include Michael P Monahan and Doug K Schillinger.
View institutional ownership trends
.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SKIN) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners